EYLEA approved to treat macular edema in central retinal vein occlusion
Yesterday, the drug EYLEA (aflibercept), an anti-vascular endothelial growth factor (VEGF) antibody, was approved by the FDA to treat macular edema associated with central retinal vein occlusion (CRVO). A central retinal … Continue reading
September 22, 2012 · 1 Comment
Pregnancy and the eye
As a retina specialist, I examine a lot of pregnant women who have diabetes. What am I looking for during those exams? Evidence of diabetic retinopathy — bleeding, cholesterol leakage, … Continue reading
June 25, 2012 · Leave a comment
